Skip to content
Adam Torkildson – Lifestyle
Author:
ROCHE DIAGNOSTICS CORPORATION
Roche expands cyclospora testing portfolio to support U.S. public health response
August 6, 2026
Roche receives FDA 510(k) clearance for cobas® c703 and cobas® ISE neo, next-generation analytical units enhancing efficiency and capability for laboratories
March 30, 2026
Roche expands mass spectrometry menu to include steroid assays receiving CLIA ‘moderate complexity’ designation
March 18, 2026